Lupin Pharmaceuticals Inc. is recalling 7,250,189 bottles of Losartan Potassium (losartan) and Losartan Potassium and Hydrochlorothiazide (losartan/hydrochlorothiazide) tablets. This prescription blood pressure medication is being recalled because certain batches were found to contain levels of an impurity known as "AZIDO" that exceed the FDA's acceptable safety limits. The recalled tablets were manufactured in India and distributed nationwide to pharmacies and distributors between 2020 and 2022.
Long-term exposure to AZIDO impurities above acceptable levels may pose a risk to patient health. While no adverse events or injuries have been reported in connection with this specific recall, the impurity levels observed violated Good Manufacturing Practice (GMP) standards.
You have 2 options:
Available in 90-count and 1000-count bottles.
Available in 90-count and 1000-count bottles.
Available in 90-count and 1000-count bottles.
Available in 30-count and 90-count bottles.
Available in 30-count and 90-count bottles.
Available in 30-count and 90-count bottles.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.